1189926-01-9

1189926-01-9 structure
1189926-01-9 structure

Name Irgarol
Synonyms 1,3,5-Triazine-2,4-diamine, N-cyclopropyl-N-(1,1-dimethylethyl)-6-(methylthio)-
Irgarol
T6N CN ENJ BS1 DMX1&1&1 FM- AL3TJ
N-Cyclopropyl-N'-(2-methyl-2-propanyl)-6-(methylsulfanyl)-1,3,5-triazine-2,4-diamine
1,3,5-Triazin-2-amine, 4-(cyclopropylimino)-N-(1,1-dimethylethyl)-1,4-dihydro-6-(methylthio)-, (4E)-
Irgarol tm
792218
N-tert-Butyl-N'-cyclopropyl-6-(methylsulfanyl)-1,3,5-triazine-2,4-diamine
cybutryne
(4E)-4-(Cyclopropylimino)-N-(2-methyl-2-propanyl)-6-(methylsulfanyl)-1,4-dihydro-1,3,5-triazin-2-amine
N-tert-Butyl-N'-cyclopropyl-6-(methylsulfanyl)-1,3,5-triazin-2,4-diamin
Description N2-(tert-Butyl)-N4-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine-d9 is the deuterium labeled N2-(tert-Butyl)-N4-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine[1].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.  

Density 1.3±0.1 g/cm3
Boiling Point 347.2±25.0 °C at 760 mmHg
Molecular Formula C11H19N5S
Molecular Weight 253.367
Flash Point 163.8±23.2 °C
Exact Mass 253.136108
LogP 1.12
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.659